|
MDH Webinar for Prescribers on COVID-19 Therapeutics |
|
|
View this as a webpage
The Minnesota Department of Health is hosting a webinar for prescribers on antiviral therapies for COVID-19 on Dec. 7, 2022, at 12-1 p.m., titled “Antiviral Therapies for COVID-19: A Review of Current Therapeutic Options.”
This one-hour presentation will provide an overview of currently authorized therapeutics options for the prevention and treatment of COVID-19 and a case-based discussion on the indications and use of various treatment options. It is intended for all health care providers who may assess patients who are at risk for COVID-19 or present with acute COVID-19 infection, including physician and non-physician prescribers in primary care, specialty care, urgent care settings, pharmacies, or in congregate settings such as long-term care facilities.
The webinar is free and registration is required. Details on speakers, learning objectives, and treatment options are available at Therapeutic Options for COVID-19 Patients.
|
|
Continuing education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Minnesota Medical Association and Minnesota Department of Health. The Minnesota Medical Association (MMA) is accredited by the ACCME to provide continuing medical education for physicians.
The Minnesota Medical Association designates this live internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
An application has been submitted to the Minnesota Board of Pharmacy for continuing education approval.
Other participants are responsible for determining if this training meets CE criteria for their professional organization.
|
|
Share this training opportunity
Please share within your network and with any colleagues who may have interest in this topic. We look forward to meeting with you!
|
|
|
|
